01
Supply Chain or Distribution Failure
Supply chain risk is broadening and becoming more complex, extending well beyond keeping shipping vessels moving or suppliers’ manufacturing facilities intact.
From early-stage biotechnology start-ups to large multinational pharmaceuticals, the life sciences industry relies on innovation to meet shifting demands in health and improve treatment outcomes around the globe. However, emerging and established risks force organizations to operate in a volatile environment. While navigating research and development challenges, supply chain impacts and barriers to commercial sales, businesses also find themselves swept up in the fight for talent.
Finding new ways to cost-effectively manage risk and attract and retain a digitally-savvy workforce will accelerate innovation to create greater efficiencies, develop personalized medical treatments and access new markets. But with ever-evolving regulation, governance and production interruptions impacting the pace of progress, businesses across this sector must be resilient, investing in end-to-end solutions for their risk and human capital, as well as workforce health and wellbeing to protect vital talent.
According to our latest Global Risk Management Survey, the biggest risks facing the Life Sciences industry include:
Report
From the global powerhouses of big pharma to the niche start-ups and technology giants venturing into the healthtech space, technology has transformed the opportunities and risks for life sciences businesses. Both innovation and digitalization have been fundamental for the research, production and distribution of medicine and medical devices.
Article 7 mins
Digitalization presents both opportunities and challenges in life sciences, driving new organizational approaches to human capital to keep up with evolving talent needs while building a resilient workforce.
Article 8 mins
As digitalization presents new risks and opportunities for life sciences organizations, implementing cyber and data resilience ensures that innovation doesn’t result in business interruption.
Article 3 mins
From global supply chain risks to climate insecurity, organizations face challenges and complexities on a scale rarely seen before.
Article 3 mins
Risk Capital CEO Andy Marcell and Human Capital CEO Lambros Lambrou discuss how innovations in Risk Capital and Human Capital can help organizations boost resilience and navigate volatility.
Article 12 mins
While digitalization is delivering transformational change to R&D across the sector, it is also rapidly reshaping recruitment and retention strategies.
Article 11 mins
Life Sciences industry respondents to our Global Risk Management Survey (GRMS) ranked supply chain or distribution failure and cyber attack or data breach as their two most critical risks.
Article 6 mins
Life sciences companies lag other industries in addressing the physical and mental health of employees and getting them future-skills ready. Here are actions to address these gaps.
Article 8 mins
AI is creating new possibilities in life sciences, especially in R&D, training and marketing. But, as the industry adapts to AI, it also faces risks and challenges.
Article 14 mins
Protecting and sustaining businesses in food, agribusiness and beverage, financial institutions, life sciences and renewables require a resilient workforce. Organizations must consider the skills, capabilities, agility and wellbeing of their people to achieve a productive and healthy workforce.
Article 6 mins
In today’s increasingly volatile global economy, business leaders are focusing on two key areas of decision-making: Risk Capital and Human Capital.
Article 7 mins
Aon’s 2022–2023 Global Wellbeing Survey explores what employers around the world are doing to support the needs of today’s workforce.
Article 7 mins
To make the most out of their ESG data, companies can draw on different approaches to benchmarking and increase their attention to governance.
Article 7 mins
Life sciences companies are trying to find a balance between navigating economic pressures and a push to innovate for the future.
Article 13 mins
Industry leaders in life sciences, financial institutions, technology, media and communications and food, agribusiness and beverage face a surge in cyber threats and data breaches.
Article 7 mins
The impact of climate change on businesses, insurers, and communities can provide insight on how to mitigate the risks associated with extreme weather events.
Article 7 mins
The life sciences industry is facing a dynamic and volatile landscape due to the COVID-19 pandemic and other global risks.
Article 12 mins
Climate disclosure requirements will increase globally in 2023. Use this guide in preparation to reduce risk and attract investors.
Article 6 mins
A new phenomenon in which employees become disengaged — 'quiet quitting' — is drawing increasing interest.
Article 7 mins
A record number of workers are quitting jobs and changing companies — or thinking about it. How can employers retain talent in today’s competitive market?